Phase I Clinical and Pharmacological Study of Cetugex, a Novel Anti-EGFR Monoclonal Antibody with an Optimized Antibody Dependent Cellular Cytotoxicity
Titel:
Phase I Clinical and Pharmacological Study of Cetugex, a Novel Anti-EGFR Monoclonal Antibody with an Optimized Antibody Dependent Cellular Cytotoxicity
Auteur:
de Dosso, S. Fiedler, W. Gianni, L. Cresta, S. Schulze-Bergkamen, H.B. Gurrieri, L. Salzberg, M. Dietrich, B. Danielczyk, A. Baumeister, H. Goletz, S. Sessa, C.